|1.||Chiliza, Bonginkosi: 2 articles (08/2015 - 05/2015)|
|2.||Emsley, Robin: 2 articles (08/2015 - 05/2015)|
|3.||Asmal, Laila: 2 articles (08/2015 - 05/2015)|
|4.||Malhotra, Anil K: 1 article (08/2015)|
|5.||Carr, Jonathan: 1 article (08/2015)|
|6.||Vink, Matthijs: 1 article (08/2015)|
|7.||Kahn, Rene S: 1 article (08/2015)|
|8.||du Plessis, Stefan: 1 article (08/2015)|
|9.||Kidd, Martin: 1 article (08/2015)|
|10.||Kilian, Sanja: 1 article (05/2015)|
|1.||Psychotic Disorders (Schizoaffective Disorder)
01/01/1984 - "Therapeutic efficacy of flupenthixol decanoate in schizoaffective disorder: a clinical evaluation."
08/17/1971 - "[Preliminary study corncerning the treatment of chronic psychoses with Flupenthixol decanoate]."
09/01/1972 - "[Action of flupentixol decanoate in chronic psychoses of the schizophrenic type]."
01/01/2014 - "Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders."
01/01/2000 - "Depot flupenthixol decanoate for schizophrenia or other similar psychotic disorders."
|2.||Schizophrenia (Dementia Praecox)
01/01/2000 - "From the data reported in clinical trials, it would be understandable if those suffering from schizophrenia, who are willing to take flupenthixol decanoate, would request the standard dose rather than the high dose. "
01/01/1998 - "[Total illness costs of schizophrenia and monetary evaluation of prevention of recurrence exemplified by a standard depot neuroleptic (flupenthixol decanoate)]."
11/01/1987 - "Double-blind comparison of half-dose and standard-dose flupenthixol decanoate in the maintenance treatment of stabilised out-patients with schizophrenia."
08/01/1979 - "High dose flupenthixol decanoate in chronic schizophrenia."
01/01/1974 - "Flupenthixol decanoate in schizophrenia."
|3.||Movement Disorders (Movement Disorder)
01/01/2000 - "Two small studies suggest that flupenthixol decanoate is responsible for less movement disorders than other depot antipsychotic drugs (OR 0.23 CI 0.08-0.7, NNT 5). "
04/01/1988 - "In patients whose acute episodes responded to treatment, pimozide taken once weekly as maintenance therapy was as effective as intramuscular flupenthixol decanoate, but tardive dyskinesia appeared in two patients receiving weekly pimozide; the repeat psychometric assessment at 12 months found modest improvements, i.e. "
|4.||Cocaine-Related Disorders (Cocaine Addiction)
|5.||Mood Disorders (Mood Disorder)
|1.||Antipsychotic Agents (Antipsychotics)
|2.||fluphenazine depot (modecate)
|3.||Risperidone (Risperdal Consta)